• Menu
  • Skip to primary navigation
  • Skip to content

Before Header

Header Right

Mobile Menu

RSS
Follow by Email
Facebook
fb-share-icon
Twitter
Visit Us
Follow Me
Tweet
LinkedIn
LinkedIn
Share
Instagram
  • Algorithms
  • Basics
  • Lectures and Cases
  • Quick Hit Article
  • About US
  • Favoritest Links

Droperidol, Ziprasidone or Ativan for Agitation Control in the ED

Droperidol, Ziprasidone or Ativan for Agitation Control in the ED

June 10, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Martel ML, Driver BE, Miner JR, Biros MH, Cole JB. Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department. Acad Emerg Med. 2021 Apr;28(4):421-434. doi: 10.1111/acem.14124. Epub 2020 Oct 5. PMID: 32888340. The answer is still Droperidol however given the small sample size this still needs to …

Category: Uncategorized

Pressure Support Or T-Piece Trials

Pressure Support Or T-Piece Trials

June 10, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

There may not be much data on which type of Weaning trial is best..But if there were Id pick this one!

Category: Uncategorized

Prophylactic or Surveillance Splenic artery embolization

Prophylactic or Surveillance Splenic artery embolization

January 20, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Category: Quick Hit ArticleTag: Trauma

A Road Map for TEE

A Road Map for TEE

January 11, 2021 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Ever Wondered where to start learning TEE? Well here is a roadmap to help understand the images. Look back soon for more learning! Download the pdf below:

Category: Algorithms

Is there a DIF between H2 and PPI’s in the mechanically ventilated ICU patient

Is there a DIF between H2 and PPI’s in the mechanically ventilated ICU patient

August 25, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Category: Quick Hit ArticleTag: GI, ICU

Only the A-E-I-O-U’s to start RRT and now we know “Y”! The Start-AKI Trial

Only the A-E-I-O-U’s to start RRT and now we know “Y”! The Start-AKI Trial

August 10, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

In residency and med school we are always taught the indications for emergent CRRT as the mnemonic: AEIOU Acidosismetabolic acidosis with a pH < 7.1 Electrolytes hyperkalemia > 6.5 mEq/L refractory to treatment or rapidly rising levels in potassiumIngestionswith dialyzable drug, including salicylates, lithium, isopropanol, methanol, and ethylene glycol (SLIME)Overloadvolume overload that does not respond …

Category: Quick Hit ArticleTag: ICU, Renal

I CAN Drive 65?…In Shock: A Trial of MAP 60-65 in Patients 65 years or older requiring vasopressors

I CAN Drive 65?…In Shock: A Trial of MAP 60-65 in Patients 65 years or older requiring vasopressors

July 29, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  1 Comment

Category: Quick Hit ArticleTag: ICU

Atrial fibrillation in the ICU: Tough AF to Treat, Sick AF to care for…

Atrial fibrillation in the ICU: Tough AF to Treat, Sick AF to care for…

July 28, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Peer Reviewed by Dr. Sagar Dave, DO Every once in a while, it’s a good thing to get down to the nitty gritty of things. I think this is most helpful in common situations. Atrial fibrillation is one of those things to have quickly accessible in your internal brain. In this episode I want to …

Category: AlgorithmsTag: Cardiology, ICU

Conservative vs Interventional Management of Spontaneous Primary Pneumothoracies (PSP)

Conservative vs Interventional Management of Spontaneous Primary Pneumothoracies (PSP)

July 16, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Category: Quick Hit ArticleTag: Emergency Medicine, Pulmonology

COVID-19 RISK FACTORS: Who gets them and why. You are going to ACE this one…

COVID-19 RISK FACTORS: Who gets them and why. You are going to ACE this one…

April 3, 2020 //  by Jesse Shriki, DO, MS RDMS FACEP//  Leave a Comment

Now usually I don’t go and make wild conjectures and hypotheses. But Im going to discuss a pretty interesting (wild conjecture?) one that on paper seems to make sense to me. Let’s look at the COVID-19 risk factors for who gets severe disease and put them in a molecular and biological framework. If you want you …

Category: DEEP DIVETag: Infectious Diseases

  • Page 1
  • Page 2
  • Page 3
  • …
  • Page 7
  • Next Page »

Site Footer

RSS
Follow by Email
Facebook
fb-share-icon
Twitter
Visit Us
Follow Me
Tweet
LinkedIn
LinkedIn
Share
Instagram

Copyright © 2022 · All Rights Reserved · Powered by Mai Theme

 

Loading Comments...